The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
2022, a year of misinformation. 2023 a year of nothing by the feel of it. No tweets, no communication, no nothing from this company and share options in the 7's for the directors. What an absolute disgrace.
The spike was based on thin air. What we is need some proper news of progress from this shower. I can't believe how poor their communication is. They have circa 80 members of staff and are recruiting. Surely something must be going on. I was pleasantly surprised by the cash balance in December.
Happy New Abingdon Year all.
Attack the BOD. LMAO as you put it. They’ve misled the market, withheld information and delivered sweet FA. Justified in my opinion. Not suggesting things can’t change but let’s not pretend it’s anything else at this point.
I see Abingdon are hiring more lateral flow development specialists. I would suggest investing in the ones currently employed. The business update would suggest there isn’t enough work to go around as it is, or maybe I’m missing something.